News Focus
News Focus
Replies to #27920 on Biotech Values
icon url

drbio45

04/30/06 9:59 PM

#27921 RE: Praveen #27920

Coley thinks that they have a blockbuster Promune. That's why they don't work weekends:-)

I drove by an open house in my neighborhood. No one lives in the house but there were a lot of cars parked in front.

hmmmm
icon url

DewDiligence

05/01/06 3:31 PM

#27979 RE: Praveen #27920

[OT] COLY drive-by addendum: although there were no cars in the lot yesterday, there was a lot of activity… about 50 Canada geese were grazing on the impressively lush lawn.
icon url

DewDiligence

05/11/06 5:04 PM

#28533 RE: Praveen #27920

COLY CC:

1. PFE plans to run three new phase-2 trials of PF-3512676 in NSCLC, each with 130-140 patients, in combination with : a) Avastin, b) Tarceva, and c) Alimta. Although COLY and PFE are not disclosing the setting or trial designs, my guess is that these trials will test each of the above agents with and without PF-3512676 in second-line NSCLC. PFE also plans a phase-2 trial of PF-3512676 in an undisclosed breast-cancer setting.

2. More Actilon data will be released at DDW later this month.

3. Employees have been directed to work on weekends.






(Just kidding about #3 :-) )